Research Articles | Page 21 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes Dec 2020 Hematology/oncology and stem cell therapy Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Plain language summary of RACE study results: addition of eltrombopag to standard treatment of severe aplastic anemia Dec 2023 Immunotherapy Aplastic Anemia
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases Apr 2023 Internal and Emergency Medicine Myelodysplastic Syndromes (MDS)
High Serum Ferritin Levels in Newly Diagnosed Patients With Myelodysplastic Syndromes Are Associated With Greater Symptom Severity Jun 2020 International Journal of Hematology Myelodysplastic Syndromes (MDS)
High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity Aug 2020 International Journal of Hematology Myelodysplastic Syndromes (MDS)
Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia Oct 2023 International Journal of Hematology Aplastic Anemia
Mutations in myelodysplastic syndromes: Core abnormalities and CHIPping away at the edges Aug 2020 International Journal of Laboratory Hematology Myelodysplastic Syndromes (MDS)
The Effect of Respiratory Viral Infections on Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria May 2023 International Journal of Molecular Sciences Paroxysmal Nocturnal Hemoglobinuria (PNH)
Young Enough to Undergo Allogeneic Transplantation for Myelodysplastic Syndromes?: Considering the Results of the Medicare Coverage With Evidence Development Study Dec 2019 JAMA Oncology Myelodysplastic Syndromes (MDS)
Genomic Biomarkers to Predict Resistance to Hypomethylating Agents in Patients With Myelodysplastic Syndromes Using Artificial Intelligence Sep 2019 JCO Precision Oncology Myelodysplastic Syndromes (MDS)